Modeled Cost-Effectiveness of a Rideshare Program to Facilitate Colonoscopy Completion

What is the modeled cost-effectiveness of providing rideshare for colonoscopy to patients with abnormal fecal immunochemical test (FIT) results?In this decision-analytic model study with 4 simulated cohorts of 10 million people, using a $100 rideshare intervention starting at age 45 years to increase colonoscopy completion from 35% to 70% cost $43 308 per 1000 people screened and was associated with saving $330 587 per 1000 people screened and 24.9 life-years gained per 1000 people screened compared with no intervention.These findings suggest that increasing colonoscopy completion in a population with abnormal FIT results via a rideshare intervention is cost saving at $100 per ride due to detecting earlier-stage colorectal cancer and preventing colorectal cancer through detection of precancerous lesions.

Corresponding Author: Rachel B. Issaka, MD, MAS, Public Health Sciences Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, M/S: M3-B232, Seattle, WA 98109 (rissaka@fredhutch.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.